NCT00186277View on ClinicalTrials.gov

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Bladder Cancer

Interventions

DRUG

Oxaliplatin

Calculated per patient

DRUG

Taxotere

Calculated per patient

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Sanofi-Synthelabo

All Listed Sponsors

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Stanford University

OTHER